ATNFW
Income statement / Annual
Last year (2023), CannBioRx Life Sciences Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, CannBioRx Life Sciences Corp.'s net income was -$19.94 M.
See CannBioRx Life Sciences Corp.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$105,675.00
|
$109,004.00
|
$116,297.00
|
$125,333.00
|
$72,244.00
|
$0.00
|
$0.00
|
Gross Profit |
-$105,675.00
|
-$109,004.00
|
-$116,297.00
|
-$125,333.00
|
-$72,244.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$2.78 M
|
$2.43 M
|
$3.95 M
|
$2.29 M
|
$2.04 M
|
$1.07 M
|
$0.00
|
General & Administrative Expenses |
$10.69 M
|
$15.47 M
|
$11.69 M
|
$3.32 M
|
$5.89 M
|
$7.67 M
|
$343,884.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$38,831.00
|
$12.96 M
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$10.69 M
|
$15.47 M
|
$11.69 M
|
$3.36 M
|
$18.85 M
|
$7.67 M
|
$343,884.00
|
Other Expenses |
$0.00
|
$246.34 B
|
$770,602.00
|
$264,739.00
|
$250,396.00
|
$0.00
|
$0.00
|
Operating Expenses |
$13.48 M
|
$39.64 M
|
$20.16 M
|
$9.82 M
|
$25.22 M
|
$14.51 M
|
$343,884.00
|
Cost And Expenses |
$13.48 M
|
$39.64 M
|
$20.16 M
|
$9.82 M
|
$25.22 M
|
$14.51 M
|
$343,884.00
|
Interest Income |
$0.00
|
$26,667.00
|
$186,208.00
|
$1.09 M
|
$181,413.00
|
$12,235.00
|
$663,017.00
|
Interest Expense |
$44.83
|
$26,667.00
|
$186,208.00
|
$1.09 M
|
$185,140.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$105,675.00
|
$109,004.00
|
$116,297.00
|
$125,333.00
|
$72,244.00
|
$23,077.00
|
$52,516.00
|
EBITDA |
-$22.13 M |
-$17.79 M |
-$20.05 M |
-$5.52 M |
-$20.79 M |
-$8.72 M |
-$343,884.00 |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
-$8.81 M
|
-$21.77 M
|
-$4.71 M
|
-$5.26 M
|
-$4.54 M
|
-$5.75 M
|
$663,017.00
|
Income Before Tax |
-$22.28 M
|
-$39.67 M
|
-$20.35 M
|
-$10.90 M
|
-$25.40 M
|
-$14.50 M
|
$319,133.00
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
-$2.35 M
|
$942,749.00
|
$23,204.00
|
$20,427.00
|
$9,496.00
|
-$1.00
|
$195,369.00
|
Net Income |
-$19.94 M
|
-$38.73 M
|
-$20.32 M
|
-$12.01 M
|
-$25.39 M
|
-$14.50 M
|
$123,764.00
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
EPS |
-52.6 |
-387.26 |
-247.86 |
-255.46 |
-875.66 |
-1449.54 |
12.38 |
EPS Diluted |
-52.59 |
-387.18 |
-246.32 |
-251.32 |
-874.45 |
-1449.54 |
12.38 |
Weighted Average Shares Out |
$379,000.00
|
$100,000.00
|
$82,000.00
|
$47,000.00
|
$29,000.00
|
$10,000.00
|
$10,000.00
|
Weighted Average Shares Out Diluted |
$379,089.00
|
$100,021.00
|
$82,514.00
|
$47,774.00
|
$29,040.00
|
$10,000.00
|
$10,000.00
|
Link |
|
|
|
|
|
|
|